Literature DB >> 21501953

Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.

S W Loo1, K Geropantas, C Beadsmoore, P Q Montgomery, W M C Martin, T W Roques.   

Abstract

AIMS: This study assessed neck control in patients with N2 head and neck squamous cell carcinoma (HNSCC) treated with sequential chemoradiotherapy (SCRT) and the incidence of neck recurrence when neck dissection was withheld in those with negative post-treatment fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET).
MATERIALS AND METHODS: Thirty-four consecutive patients with N2 HNSCC who were treated with radical intent using SCRT were included. Twenty-seven patients received concomitant platinum-based chemotherapy with their radiotherapy. Nineteen patients were treated with intensity-modulated radiotherapy. PET-computed tomography (PET-CT) was obtained 3 months after the completion of radical radiotherapy. Neck dissection was carried out only in those with increased FDG uptake in the neck.
RESULTS: The median follow-up was 39.1 months. One patient had increased FDG uptake in the neck post-treatment, which was false positive for malignancy. The remaining 33 patients were observed without neck dissection. No regional recurrence occurred. The negative predictive value (NPV) of post-treatment PET-CT was 100%.
CONCLUSIONS: Good disease control in the neck can be achieved in patients with N2 HNSCC with SCRT. Post-treatment PET-CT has a high NPV. Neck dissection can be avoided if post-treatment PET-CT is negative.
Copyright © 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21501953     DOI: 10.1016/j.clon.2011.03.008

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  8 in total

1.  The role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy.

Authors:  J M Sherriff; B Ogunremi; S Colley; P Sanghera; A Hartley
Journal:  Br J Radiol       Date:  2012-06-27       Impact factor: 3.039

Review 2.  Emerging biomarkers in head and neck cancer in the era of genomics.

Authors:  Hyunseok Kang; Ana Kiess; Christine H Chung
Journal:  Nat Rev Clin Oncol       Date:  2014-11-18       Impact factor: 66.675

3.  CT-based follow-up following radiotherapy or radiochemotherapy for locally advanced head and neck cancer; outcome and development of a prognostic model for regional control.

Authors:  Daan Nevens; Olivier Vantomme; Annouschka Laenen; Robert Hermans; Sandra Nuyts
Journal:  Br J Radiol       Date:  2016-10-06       Impact factor: 3.039

4.  Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.

Authors:  Charles Marcus; Anthony Ciarallo; Abdel K Tahari; Esther Mena; Wayne Koch; Richard L Wahl; Ana P Kiess; Hyunseok Kang; Rathan M Subramaniam
Journal:  J Nucl Med       Date:  2014-06-19       Impact factor: 10.057

5.  FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance.

Authors:  Nils Helsen; Tim Van den Wyngaert; Laurens Carp; Sigrid Stroobants
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-24       Impact factor: 9.236

6.  The prognostic value of location and size change of pathological lymph nodes evaluated on CT-scan following radiotherapy in head and neck cancer.

Authors:  Daan Nevens; Olivier Vantomme; Annouschka Laenen; Robert Hermans; Sandra Nuyts
Journal:  Cancer Imaging       Date:  2017-02-28       Impact factor: 3.909

7.  F-18 FDG PET-CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India.

Authors:  Justin Benjamin; Julie Hephzibah; Nylla Shanthly; Regi Oommen; David Mathew; Simon Pavamani; Janakiraman Rajnikanth
Journal:  Cancer Rep (Hoboken)       Date:  2021-03-03

8.  Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study.

Authors:  Ryul Kim; Chan-Young Ock; Bhumsuk Keam; Tae Min Kim; Jin Ho Kim; Jin Chul Paeng; Seong Keun Kwon; J Hun Hah; Tack-Kyun Kwon; Dong-Wan Kim; Hong-Gyun Wu; Myung-Whun Sung; Dae Seog Heo
Journal:  BMC Cancer       Date:  2016-02-17       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.